Krystal Biotech, Inc. (NASDAQ:KRYS) is held by 326 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 5,777,776 | 2,999,999 | 108.00% | $1,424,452,896.00 |
| FMR LLC | 31 Dec, 2025 | 4,373,987 | 24,359 | 0.56% | $1,129,888,252.00 |
| FMR LLC | 31 Dec, 2025 | 4,349,628 | 8,181 | 0.19% | $1,072,357,209.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,940,456 | 2,639 | 0.07% | $1,017,898,595.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,937,817 | 103,689 | 2.70% | $970,829,404.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 2,888,888 | -2,888,888 | -50.00% | $746,257,548.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,778,845 | -13,363 | -0.48% | $685,096,446.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Dec, 2025 | 1,456,727 | 1,456,727 | 0.00% | $376,301,719.00 |
| State Street Corp | 31 Dec, 2025 | 1,342,303 | -53,664 | -3.84% | $330,931,382.00 |
| State Street Corp | 31 Dec, 2025 | 1,314,434 | -27,869 | -2.08% | $339,544,591.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,165,324 | 1,165,324 | 0.00% | $301,026,496.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 1,153,087 | 212,028 | 22.53% | $297,865,434.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 941,059 | -77,772 | -7.63% | $232,008,686.00 |
| Capital World Investors | 31 Dec, 2025 | 824,720 | 15,220 | 1.88% | $213,041,670.00 |
| Capital World Investors | 31 Dec, 2025 | 809,500 | 260 | 0.03% | $199,574,130.00 |
| Redmile Group, LLC | 31 Dec, 2025 | 677,705 | 16,317 | 2.47% | $167,081,391.00 |
| Redmile Group, LLC | 31 Dec, 2025 | 673,505 | -4,200 | -0.62% | $173,979,812.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 643,975 | 32,097 | 5.25% | $166,383,833.00 |
| Hood River Capital Management LLC | 31 Dec, 2025 | 619,586 | 6,284 | 1.02% | $160,051,456.00 |
| Hood River Capital Management LLC | 31 Dec, 2025 | 613,302 | 6,356 | 1.05% | $151,203,475.00 |